🔴 Indaptus Therapeutics is trading 6.1% down today with no clear catalyst

Indaptus Therapeutics is trading 6.1% down at $2.60 in pre-market sessions after several days of steady gains earlier this week.

• There are no fresh company-specific headlines, earnings releases, or analyst calls linked to the move so far.
• The price action likely reflects normal volatility and light pre-market liquidity rather than a clear fundamental catalyst.